Pathology EMQ template.

Name: Sarah Castle

Candidate number: 00399099

Theme: Chronic Myeloid Leukaemia

OPTION LIST

A	50%	I	22 years
B	Nilotinib	J	Busulphan
C	Months to 4-5 years	K	69%
D	43-64%	L	Imantinib
E	2 weeks	M	30-45 years
F	55-60 years	N	Bone marrow analysis
G	Fine needle aspirate	O	RT-PCR
H	10-19%	P	Enzymology

For each scenario below, choose the most appropriate answer from the list above. Each option may be used once, more than once or not at all.

1. First line treatment for all patients with new diagnosed Chronic Myeloid Leukaemia

2. Median age of onset of CML

3. Method of assessing residual or relapsed leukaemia

4. Approximate length of chronic phase in CML

5. Proportion of blast cells in the accelerated phase of CML

ANSWERS

1. L

2. F

3. O

4. C

5. H